Top Buyout Firms Club Up for Jumbo LBO of Medline
(Bloomberg) -- At least eight buyout firms are preparing offers for Medline Industries Inc., a medical supply company that could fetch about $30 billion, according to people familiar with the matter. In a sign that club deals are back, some are partnering up for what could be one of the biggest leveraged buyouts on record.
Bain Capital, Advent International and CVC Capital Partners have teamed up on a potential bid, said the people, who asked to not be identified because the matter isn't public. KKR & Co. is working on an offer potentially teaming up with Clayton Dubilier & Rice, the people said. Blackstone Group Inc. has partnered with Hellman & Friedman while Apollo Global Management Inc. is also weighing an offer, they said. First round bids are due in mid-May, the people said.
Banks are seeking to align with potential buyers to help provide financing that will likely exceed $10 billion, the people said. It's possible a deal won't be reached and the company could opt to divest a stake or pursue an initial public offering.
“At this time, we have no details to share about the process,” a representative for Medline said in a statement. “Any future decisions will reflect the intent of the Mills family to continue to lead Medline and be a significant owner of the company.”
Representatives for all the private equity firms declined to comment.
At $30 billion, a deal for Medline could potentially be one of the top-five leveraged buyouts ever, according to data compiled by Bloomberg.
It could also mark the return of club deals, in which several private equity firms team up to acquire a company, something that became rarer after the financial crisis. They lost favor with investors in private equity funds because they don't like having too much money exposed to the same asset. Several high-profile club deals also ended in bankruptcy, including the $45 billion takeover of the utility TXU Corp., the biggest leveraged buyout on record.
Based in Northfield, Illinois, Medline is the biggest private U.S. manufacturer and distributor of medical supplies like medical gloves, gowns and exam tables to hospitals and doctor's offices.
During the Coronavirus pandemic it expanded manufacturing in North America to produce face masks and hand sanitizer to meet the explosion in demand for medical supplies, according to its website. The company generated $17.5 billion in sales in 2020, according to a representative for the company.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.